Rallybio to Present at the Jefferies Healthcare Conference

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: September 21, 2023

GMS Board Members Recognized for Excellence in Board Leadership • Multi-Million-Dollar Gift from the Nanji Family Foundation to Expand the Aga Khan Museum's Global Impact with the Aim of U • Built with Integration: Metrikus Announces Integration with ServiceNow to Enhance Workplace Efficiency, Sustainability and ROI o • It's Back-to-School and LuvBug Learning Reports 9 in 10 Parents Feel Interactive Tools at Home can Improve Academic Performance • Gravitas Education Holdings Inc. Announces Special Cash Dividend in the Range of US$11.256 to US$12.17 per American Depositary S • CollPlant Biotechnologies Joins the United Nations Global Compact, The World's Largest Corporate Sustainability Initiative • Vast Receives Equity Commitment for up to USD $10 Million From Canberra Airport Group • Pyrowave Introduces Nanopurification Technology: A revolutionary short-loop chemical recycling innovation to remove toxic additi • lululemon’s Third Annual Global Wellbeing Report Reveals the “Wellbeing Dilemma”: Though People Are Increasing • Cresco Labs Expands Florida Brand Portfolio with Launch of FloraCal and Cresco Live Rosin and Flower Products • 2024 Toyota RAV4: Go Wild in Style • Indeed’s “AI at Work Report” Finds GenAI will Impact Almost Every Job in America • CPSC Urges Parents and Caregivers to Check Baby's Sleep Space During Baby Safety Month; Shares Dos and Don'ts for Infant Sleep S • ICE to Launch CORSIA Carbon Credit Futures Market to Manage Emissions Exposure from Airlines • Consumers Energy Proposes Renewable Energy Offerings, Providing Greater Access and Affordability to Michiganders • The Boris Lawrence Henson Foundation and Founder, Taraji P. Henson Announce "Joy Joints!" A National Campaign to Reignite Commun • GlobalData Report Highlights Staggering Economic Costs for New York of $37.3 Billion Due to Obesity • The University of Queensland and Oxford Nanopore Technologies Team up to Accelerate Research Into Quality Control Testing for mR • Civil Rights Advocates Call on D.C. City Council to Scuttle Legislation That Would Subject D.C. Black Residents to Implicit Bias • MAKITA U.S.A. WELCOMES SEAN OKADA AS NEW PRESIDENT AND CEO

Rallybio to Present at the Jefferies Healthcare Conference

NEW HAVEN, Conn. , June 01 /Businesswire/ - Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today announced that Company management will participate in a fireside chat at the Jefferies Healthcare Conference on Friday, June 9 at 9:00AM ET in New York, NY.

A live webcast of the fireside chat will be accessible through the Events and Presentations section of Rallybio’s website at www.rallybio.com. An archived replay of the webcast will be available for 30 days following the presentation.

About Rallybio

Rallybio (NASDAQ: RLYB) is a clinical-stage biotechnology company with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases. Rallybio has built a broad pipeline of promising product candidates aimed at addressing diseases with unmet medical need in areas of maternal fetal health, complement dysregulation, hematology, and metabolic disorders. The Company has two clinical stage programs: RLYB212, an anti-HPA-1a antibody for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT) and RLYB116, a C5 complement inhibitor with the potential to treat several diseases of complement dysregulation, as well as additional programs in preclinical development.

Rallybio is headquartered in New Haven, Connecticut with an additional facility at the University of Connecticut’s Technology Incubation Program in Farmington, Connecticut. For more information, please visit www.rallybio.com and follow us on LinkedIn.